Affiliation:
1. Fourth Affiliated Hospital of Nanjing Medical University
Abstract
Abstract
Objective
This study leverages public database resources to investigate the cellular and molecular mechanisms in IgA nephropathy, a major contributor to chronic kidney disease, using single-cell RNA sequencing (scRNA-seq) analysis.
Methods
Publicly available scRNA-seq datasets of kidney biopsy samples from IgA nephropathy patients and healthy individuals were analyzed. We conducted a detailed transcriptomic profiling of individual cells to identify distinct cell populations and their roles in IgA nephropathy. The study focused on delineating the inflammatory microenvironment and assessing the functional status of critical cell types, notably podocytes and fibroblasts.
Results
Transcriptomic analysis revealed significant alterations across various cell types in the context of IgA nephropathy. Podocytes displayed substantial functional impairment, evident from altered gene expression related to glomerular filtration and structural maintenance. In parallel, renal fibroblasts were activated, exhibiting a transcriptional profile indicative of fibrosis. These findings highlight a pathogenic microenvironment dominated by inflammation and fibrosis, which is central to the progression of IgA nephropathy. The study also shed light on potential molecular targets and pathways that may be implicated in the disease's pathogenesis.
Conclusion
Employing data from public databases, this study underscores the power of single-cell technologies in dissecting the complex pathophysiology of IgA nephropathy. The insights gained into cell-specific transcriptomic changes offer novel perspectives on the disease mechanisms and suggest potential avenues for therapeutic development. This approach marks a significant step in advancing our understanding of IgA nephropathy and highlights the potential of public datasets in facilitating biomedical research, especially in the realm of personalized medicine.
Publisher
Research Square Platform LLC
Reference26 articles.
1. [An apparently benign glomerular nephropathy: intercapillary fibrinoid deposits];Morel-Maroger L;La Presse medicale,1968
2. A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy;Mathur M;The New England journal of medicine,2024
3. The pathophysiology of IgA nephropathy;Suzuki H;Journal of the American Society of Nephrology: JASN,2011
4. New developments in the genetics, pathogenesis, and therapy of IgA nephropathy;Magistroni R;Kidney international,2015
5. Single-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors;Young MD;Science (New York, N.Y.),2018